The data shows the top targeted diseases by number of products in the overall pharmaceutical industry pipeline, with a special focus on the needs of developing countries, as of 2016. At this time, there were 35 products along the pipeline dedicated to treating malaria. Most products currently being developed are for infectious diseases. These figures represent the market opportunity and medical needs for these specific medications.
Lower respiratory infections | 52 |
Diabetes | 41 |
Viral hepatitis | 35 |
Malaria | 35 |
HIV/AIDS | 32 |
Kidney diseases | 27 |
Asthma | 26 |
COPD | 22 |
Tuberculosis | 21 |
Schizophrenia | 18 |